Chapter 27 — Further Reading

Textbooks

• Clayden, Greeves, and Warren. Organic Chemistry, 2nd ed. (Oxford University Press, 2012). Chapter 21 ("Enolates and Enols"). The clearest treatment of α-carbon chemistry available; mechanism-first like our textbook.

• McMurry, John. Organic Chemistry, 9th or later ed. (Cengage). Chapter 22 ("Carbonyl α-Substitution Reactions"). Functional-group-by-functional-group treatment, complementary to ours.

• Carey and Sundberg. Advanced Organic Chemistry, Part B: Reactions and Synthesis, 5th ed. (Springer, 2007). Chapter 1 ("Alkylation of Enolates and Other Carbon Nucleophiles"). Detailed kinetic and stereochemical analysis.

• Walsh, Christopher T. (1979). Enzymatic Reaction Mechanisms (W. H. Freeman). Chapter 5 covers PLP-dependent enzymes in detail. The bridge between Chapter 27's chemistry and amino acid metabolism.

• Heathcock, C. H. (1984). The Aldol Reaction: Group I and II Enolates (academic review article in Comprehensive Organic Synthesis). Classic reference for α-carbon chemistry; somewhat advanced but excellent.

• Smith, Michael B. March's Advanced Organic Chemistry, 7th ed. (Wiley, 2013). Chapter 13 covers carbonyl α-chemistry; reference for advanced mechanism.

Primary literature

• Snyder, S. A., and Boger, D. L. (2008). "Chemistry: a privileged structure." Chemical Reviews 108(4), 1071–1116. Review of how α-carbonyl chemistry has driven synthesis of natural products and drugs.

• Hauser, C. R. (1947). "Acetic and benzoic anhydrides in carbonyl chemistry: ester condensation." Chemical Reviews 40(2), 213–250. Early treatment of Claisen and related chemistry by one of the pioneers.

• Stork, G., and Saccomano, N. A. (1987). The Stork enamine alkylation series. Tetrahedron 43(13), 2635–2649. Key papers on the enamine method.

• Eriksson, T., Björkman, S., and Roth, B. (1995). "Stereospecific determination, chiral inversion in vitro and pharmacokinetics in humans of the enantiomers of thalidomide." Chirality 7(1), 44–52. Quantitative measurement of thalidomide racemization rate.

• Knabe, J., and Niesert, A. P. (1985). On thalidomide. Pharmazie 40(1), 5–14. Chemistry of thalidomide and its derivatives.

• Toney, M. D. (2005). "Reaction specificity in pyridoxal phosphate enzymes." Archives of Biochemistry and Biophysics 433(1), 279–287. Review of how PLP enzymes select among the four major reaction types.

• Jansonius, J. N. (1998). "Structure, evolution and action of vitamin B6-dependent enzymes." Current Opinion in Structural Biology 8(6), 759–769. The structural biology of PLP enzymes.

• Wolfenden, R. (2011). "Benchmark reaction rates, the stability of biological molecules in water, and the evolution of catalytic power in enzymes." Annual Review of Biochemistry 80, 645–667. Includes data on amino acid racemization rates with and without enzymes.

• Mukaiyama, T. (1979). "The enol silyl ethers of ketones; their reactions and applications in synthesis." Angewandte Chemie 18(7), 707–721. The Mukaiyama aldol method.

Industrial and pharmaceutical references

• Stephens, T., and Brynner, R. (2001). Dark Remedy: The Impact of Thalidomide and Its Revival as a Vital Medicine. Basic Books. The story of thalidomide; chemistry context in chapters 5–7.

• Bartholomeu, D. C., and Ramos, M. S. (2017). "Lenalidomide and pomalidomide: history, mechanism, and clinical use." Anti-Cancer Drugs 28(2), 119–127. Modern thalidomide-derived drugs.

• Krönke, J., et al. (2014). "Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells." Science 343(6168), 301–305. Mechanism of lenalidomide and the discovery of cereblon as the target.

• Lu, G., et al. (2014). "The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins." Science 343(6168), 305–309. Independent confirmation of the cereblon mechanism.

Computational and reference

• Avogadro (https://avogadro.cc/). Use to optimize 2,4-pentanedione's enol form and visualize the intramolecular H-bond.

• PubChem (https://pubchem.ncbi.nlm.nih.gov/). Look up: thalidomide (CID 5426), lenalidomide (CID 216326), L-alanine (CID 5950), pyridoxal phosphate (CID 1051).

• Biological Magnetic Resonance Bank (BMRB) (https://bmrb.io/). Search for ¹H NMR data on enol forms of acetylacetone, vitamin C, and other 1,3-dicarbonyls.

Online resources

• Master Organic Chemistry, "Enols and Enolates" series (https://www.masterorganicchemistry.com/). Free, undergraduate-level mechanistic explanations.

• Khan Academy: Organic Chemistry — videos on α-carbon chemistry; mechanism-friendly.

For practice problems

• Klein, David. Organic Chemistry as a Second Language, 4th ed. (Wiley). The "second-semester" volume covers enolate chemistry. Klein's scaffolded approach is excellent for solidifying the patterns of α-C reactivity.

• Karty, Joel. Organic Chemistry: Principles and Mechanisms, 2nd ed. (W. W. Norton, 2018). Chapter on α-carbon chemistry is well-paced.

Mathematically inclined readers

• Brouwer, A. J., et al. (1995–2007). DFT calculations of α-H pKas from first principles. The ability to predict pKa from quantum chemistry was a major advance in the 2000s; agreements with experiment within 1 pKa unit.

• Streitwieser, A. (1961). Molecular Orbital Theory for Organic Chemists (Wiley). Treatment of the enolate's MO structure.

Notes on this chapter's pedagogy

Chapter 27 is the gateway to the second half of carbonyl chemistry. By treating α-C chemistry as the third reactivity family alongside addition and acyl substitution, our textbook unifies what other texts treat as separate topics (enolization, alkylation, halogenation, aldol, Claisen).

The unifying view requires the student to understand: 1. Why the α-H is acidic (resonance into C=O). 2. Why the conjugate base is a carbon nucleophile (the α-C carries some negative charge). 3. How that carbon nucleophile can attack different electrophiles (alkyl halides, X₂, other C=O, etc.).

Once these three concepts are clear, every reaction in Chs 27–29 becomes "the same chemistry, with a different electrophile." This is the mechanism-first pedagogy at its most powerful.

The Ch 27 capstone — the thalidomide racemization story — is one of the most powerful pharmaceutical chemistry vignettes in the book. It shows how a single chemical principle (α-C acidity) had massive real-world consequences. Use this story to motivate students; then return to it when discussing PROTACs (Ch 36).